CI — Cell Impact AB (publ) Share Price
Last trade - 00:00- SEK76.92m
- SEK19.77m
- SEK47.26m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.25 | ||
| Price to Tang. Book | 0.26 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.63 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -35.8% | ||
| Return on Equity | -38.68% | ||
| Operating Margin | -252.83% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 12 | 29.31 | 81.8 | 76.81 | 47.26 | 90 | 170 | 47.27% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Cell Impact publ AB is a Sweden-based company, which is active within the industrial sector. The Company develops and markets High Velocity Impact Units (HVI-U), which can be used to shape and shear material by using high kinetic energy. The energy is transferred into the material by an impact generating an extreme pressure within a fraction of a second. Its products have an impact energy from about 100 to 12,800 Joule. The HVI-U can be used for different purposes, such as embossing, creating coining type of patterns and replacing manufacturing methods, such as etching and milling. Additionally, the Company offers production of bipolar plates for fuel cells and heat exchanger plates, among others.
Directors
- Baard Eilertsen CHM
- Par Teike CEO (55)
- Stefan Axellie CFO
- Daniel Vallin COO
- Anders Oberg CTO (52)
- Achim Zeiss OTH
- Thomas Carlstrom DRC (67)
- Harriet Lidh DRC
- Kjell Ostergren DRC (66)
- Tord Andersson IND (61)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- October 1st, 1999
- Public Since
- February 20th, 2013
- No. of Employees
- 80
- Sector
- Machinery, Equipment & Components
- Industry
- Industrials
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 591,667,832
- Address
- Kallmossvagen 7 A, KARLSKOGA, 691 52
- Web
- https://www.cellimpact.com/
- Phone
- +46 586673446
- Auditors
- Ohrlings PricewaterhouseCoopers AB
Upcoming Events for CI
Similar to CI
Acuvi AB
OMX Nordic Exchange Stockholm
Alfa Laval AB
OMX Nordic Exchange Stockholm
Alimak AB (publ)
OMX Nordic Exchange Stockholm
Alligo AB
OMX Nordic Exchange Stockholm
AQ AB
OMX Nordic Exchange Stockholm
FAQ
As of Today at 19:05 UTC, shares in Cell Impact AB (publ) are trading at SEK0.13. This share price information is delayed by 15 minutes.
Shares in Cell Impact AB (publ) last closed at SEK0.13 and the price had moved by -98.18% over the past 365 days. In terms of relative price strength the Cell Impact AB (publ) share price has underperformed the FTSE Global All Cap Index by -98.34% over the past year.
There is no consensus recommendation for this security.
Cell Impact AB (publ) does not currently pay a dividend.
Cell Impact AB (publ) does not currently pay a dividend.
Cell Impact AB (publ) does not currently pay a dividend.
To buy shares in Cell Impact AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK0.13, shares in Cell Impact AB (publ) had a market capitalisation of SEK76.92m.
Here are the trading details for Cell Impact AB (publ):
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: CI
Based on an overall assessment of its quality, value and momentum Cell Impact AB (publ) is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cell Impact AB (publ). Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -84.22%.
As of the last closing price of SEK0.13, shares in Cell Impact AB (publ) were trading -91.2% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Cell Impact AB (publ) PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK0.13.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Cell Impact AB (publ)'s management team is headed by:
- Baard Eilertsen - CHM
- Par Teike - CEO
- Stefan Axellie - CFO
- Daniel Vallin - COO
- Anders Oberg - CTO
- Achim Zeiss - OTH
- Thomas Carlstrom - DRC
- Harriet Lidh - DRC
- Kjell Ostergren - DRC
- Tord Andersson - IND